Cara Therapeutics OverviewCara Therapeutics EBIT
EBIT (Earnings Before Interest and Taxes) analysis for CARA.
Quarterly EBIT
-$7.05M
As of Mar 31, 2026
Annual EBIT (TTM)
-$34.21M
↓ 58.11% YoY
Trailing 12 months ending Mar 31, 2026
Cara Therapeutics OverviewEBIT (Earnings Before Interest and Taxes) analysis for CARA.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026